Articles Referencing ILMN
QIAGEN Downgraded to Strong Sell - Analyst Blog
5/21/2013, 2:24 pm from Zacks.com in Investing, Business, Stocks
Zacks Investment Research downgraded QIAGEN
N.V. ( QGEN ) to a Zacks Rank
#5 (Strong Sell) on May 16. Why the Downgrade?
Earnings momentum for this molecular diagnostics company... Read >>
Much Awaited Test Launch by Genomic - Analyst Blog
5/15/2013, 3:28 pm from Zacks.com in Investing, Business, Stocks
Recently, Genomic Health Inc. ( GHDX ) made available
its lead pipeline candidate Oncotype DX prostate cancer test to
physicians and their patients. This comes as a major boost to... Read >>
Myriad Soars Higher on Celeb Clout - Analyst Blog
5/15/2013, 2:27 pm from Zacks.com in Investing, Business, Stocks
Shares of Myriad Genetics Inc. ( MYGN ) touched a new
52-week high of $34.70 on Tuesday, May 14, 2013 following news out
of Hollywood. Academy Award winning Hollywood star Angelina... Read >>
Illumina Beats on Earnings, Revenue - Analyst Blog
4/23/2013, 3:11 pm from Zacks.com in Investing, Business, Earnings, Stocks
Illumina Inc.'s ( ILMN ) first-quarter
2013 adjusted earnings of 46 cents per share beat the Zacks
Consensus Estimate by 21%. Adjusted earnings grew almost 28% over
the prior-year quarter... Read >>
Mid-Day Market Update: II-VI Declines On Weak Results, Netflix Spikes Higher
4/23/2013, 12:54 pm from Benzinga in Investing, Commodities, Economy, International
Midway through trading Tuesday, the Dow traded up 1 percent to
14,712.23 while the NASDAQ surged 1.27 percent to 3,274.59. The
S&P also rose, gaining 1.06 percent to 1,578.99. Index... Read >>
After-Hours Earnings Report for April 22, 2013 : CNI, TXN, ACE, RCI, AMP, NFLX, ILMN, NXPI, ZION, PKG, IEX, ELS
4/22/2013, 2:00 pm from NASDAQ.com News in News Headlines, Earnings
The following companies are expected to report earnings after
hours on 04/22/2013. Visit our Earnings
Calendar for a full list of expected earnings releases. Canadian National Railway Company... Read >>
PerkinElmer, Inc. (PKI) Ex-Dividend Date Scheduled for April 17, 2013
4/16/2013, 9:00 am from NASDAQ.com News in News Headlines, Stocks
PerkinElmer, Inc. ( PKI ) will begin
trading ex-dividend on April 17, 2013. A cash dividend payment of
$0.07 per share is scheduled to be paid on May 10, 2013.
Shareholders who purchased PKI... Read >>
Illumina Introduces TruSight Tumor - Analyst Blog
4/8/2013, 6:10 pm from Zacks.com in Investing, Business, Stocks
Recently, Illumina Inc. ( ILMN ) expanded its
suite of TruSight content sets by adding TruSight Tumor to its
portfolio. TruSight's content set is created according to different
diseases.... Read >>
FEI Company (FEIC) Ex-Dividend Date Scheduled for April 08, 2013
4/5/2013, 9:00 am from NASDAQ.com News in News Headlines, Stocks
FEI Company ( FEIC ) will begin
trading ex-dividend on April 08, 2013. A cash dividend payment of
$0.08 per share is scheduled to be paid on April 23, 2013.
Shareholders who purchased FEIC... Read >>
Affymetrix Inks Deal with UK Biobank - Analyst Blog
3/28/2013, 2:29 pm from Zacks.com in Investing, Business, Stocks
Genetic products company, Affymetrix Inc. ( AFFX ) entered into a
major contract with UK Biobank, a long-term epidemiological study
investigating complex human diseases affecting public... Read >>
Three Gurus Hold a Major Stake in LIFE
3/26/2013, 10:24 am from GuruFocus in Investing
For the past few months, Life Technologies Corporation ( LIFE ) , the
global biotechnology company that makes DNA-sequencing equipment,
laboratory instruments and lab testing products, is... Read >>
Quest's New Prenatal Testing Tie Up - Analyst Blog
2/22/2013, 2:30 pm from Zacks.com in Investing, Business, Stocks
A new coalition has been formed between leading diagnostic
testing company, Quest Diagnostics ( DGX ) and Natera, a
genetic testing company with proprietary bioinformatics-based
technology... Read >>
Affymetrix Links Up with DNA Link - Analyst Blog
2/11/2013, 12:20 pm from Zacks.com in Investing, Business, Stocks
Genetic products company, Affymetrix Inc. ( AFFX ), inked a
'Powered by Affymetrix' ("PbA") Program agreement with Korea-based
biotechnology company, DNA Link Inc. Following the... Read >>
Affymetrix's 4Q EPS In Line - Analyst Blog
2/1/2013, 9:18 am from Zacks.com in Investing, Business, Stocks
Global genetic devices maker, Affymetrix Inc.
's ( AFFX )
fourth-quarter 2012 adjusted loss of 2 cents per share was in line
the Zacks Consensus Estimate. The adjusted loss excludes... Read >>
Illumina Posts an Impressive 4Q - Analyst Blog
1/29/2013, 8:50 am from Zacks.com in Investing, Business, Stocks
Illumina ( ILMN ) reported fourth
quarter 2012 adjusted earnings per share ("EPS") of 42 cents,
beating the Zacks Consensus Estimate by a penny and 2 cents above
the year-ago... Read >>